Teva octreotide acetate injection recalled over sterility assurance deficiencies
Teva is recalling twelve lots of Octreotide Acetate for Injectable Suspension after quality system deficiencies were identified during an FDA inspection at the contract manufacturer.
- Product
- OCTREOTIDE ACETATE — OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)
- Category
- Drug
- Distribution
- Distributed nationwide